The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Oral Presentation(B) Pharmaceutical Physics

[28-08-am]Radiochemistry-1

Fri. Mar 28, 2025 1:15 PM - 2:51 PM JST
Fri. Mar 28, 2025 4:15 AM - 5:51 AM UTC
Room 8 (Fukuoka International Congress Center: 409+410 [4F])
Chair: Yumi Yamamoto, Naoya Kondo
1:15 PM - 1:27 PM JST(4:15 AM - 4:27 AM UTC)

[28-08-pm01S]Development of 111In/225Ac-labeled PSMA-targeting radiotheranostic agent using novel linker technology

○Nobuki Kazuta1, Kazuma Nakashima1, Yuta Tarumizu2, Yoshifumi Maya2, Hiroyuki Watanabe1, Masahiro Ono1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. NMP)
1:27 PM - 1:39 PM JST(4:27 AM - 4:39 AM UTC)

[28-08-pm02S]Fundamental evaluation of 125I-labeled PSMA-targeting agents for development of novel 211At-labeled agents

○Honoka Asahina1, Kazuma Nakashima1, Takuma Hasegawa1, Hiroyuki Fujimoto2, Masashi Murakami3, Kazuhiro Ooe3, Atsushi Toyoshima3, Hiroyuki Watanabe1, Masahiro Ono1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. Agency for Health, Safety and Environment, Kyoto University, 3. Institute for Radiation Sciences, Osaka University)
1:39 PM - 1:51 PM JST(4:39 AM - 4:51 AM UTC)

[28-08-pm03S]Development of novel albumin binder- conjugated radiopharmaceutical targeting fibroblast activation protein

○Kosuke Saito1, Hiroyuki Watanabe1, Keisei Yamaguchi1, Kazuma Nakashima1, Masahiro Ono1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
1:51 PM - 2:03 PM JST(4:51 AM - 5:03 AM UTC)

[28-08-pm04S]Cancer theranostics using 111In/225Ac-labeled PSMA-targeting agents with positively charged units

○Takuma Hasegawa1, Kazuma Nakashima1, Yuta Tarumizu2, Masatoshi Tada2, Michihiko Tsushima2, Yoshifumi Maya2, Hiroyuki Watanabe1, Masahiro Ono1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. Nihon Medi-Physics Co., Ltd.)
2:03 PM - 2:15 PM JST(5:03 AM - 5:15 AM UTC)

[28-08-pm05S]Development of the nuclear localization probe targeting αvβ3 integrin to achieve effective therapeutic effects of targeted radionuclide therapy

○Hiroaki Echigo1, Masayuki Munekane1, Kenji Mishiro2, Takeshi Fuchigami1, Kohshin Washiyama3, Masaharu Hazawa2, Kazuhiro Takahashi3, Seigo Kinuya4, Kazuma Ogawa1,2 (1. Grad. Sch. Pharm., Kanazawa Univ., 2. InFiniti., Kanazawa Univ., 3. Fukushima Med. Univ., 4. Grad. Sch. Med., Kanazawa Univ.)
2:15 PM - 2:27 PM JST(5:15 AM - 5:27 AM UTC)

[28-08-pm06S]Evaluation of radiohalogenated ADAM8 antibodies as theranostic agents for pancreatic cancer

○Kengo Kaida1, Takeshi Fuchigami1, Masayuki Munekane1, Kenji Mishiro2, Masashi Murakami3, Kazuhiro Ooe3, Atsushi Toyoshima3, Kazuma Ogawa1,2 (1. Grad. Sch. Pharm., Kanazawa Univ, 2. InFiniti., Kanazawa Univ, 3. Inst. Rad. Sci., Osaka Univ.)
2:27 PM - 2:39 PM JST(5:27 AM - 5:39 AM UTC)

[28-08-pm07S]Development of thermosensitive liposomes encapsulating I-125-labeled DNA-targeted compounds for Auger electron therapy

○Kazuki Matsunaga1, Masayuki Munekane1, Miki Ozaki1, Kenji Mishiro2, Takeshi Fuchigami1, Kazuma Ogawa1,2 (1. Grad. Sch. Pharm., Kanazawa Univ., 2. InFiniti., Kanazawa Univ.)
2:39 PM - 2:51 PM JST(5:39 AM - 5:51 AM UTC)

[28-08-pm08S]Development of a novel
radioimmunotherapeutic agents targeting EpCAM

○Sato Oshige1, Marina Omokawa2, Takumi Iwasawa3, Kazunori Kato3, Hiroyuki Kimura4 (1. Health Sci., Kanazawa Univ., 2. Okayama Univ., 3. Toyo Univ, 4. Disease Ctr., Kanazawa Univ.)
Back to Category List